您的位置: 首页 > 2020年1月 第51卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

内镜下精准断流术治疗食管胃静脉曲张的临床应用

Clinical application of endoscopic selective varices devascularization for esophagogastric varicose

来源期刊: 广州医药 | 19-23 发布时间:2021-11-28 收稿时间:2025/11/13 17:56:36 阅读量:12
作者:
关键词:
食管胃静脉曲张精准断流术肝硬化
Esophagogastric varicesEndoscopic selective varices devascularizationHepatocirrhosis
DOI:
10.3969/j.issn.1000-8535.2020.01.005
收稿时间:
2019-08-09 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨食管胃静脉曲张精准断流术与改良“三明治”法治疗食管胃静脉曲张的临床疗效。方法 选取共50例食管胃底静脉曲张患者,按随机数字法分为精准治疗组和对照组,精准治疗组(n=25)行内镜下食管胃静脉曲张精准断流术,对照组(n=25)接受改良“三明治”法内镜治疗。分析对比两组的止血成功率、再出血率、治疗显效率、并发症发生率、聚桂醇和组织胶用量、治疗时间及住院天数等指标。结果 治疗后随访3个月,术后3天内止血率两组均为100%。再出血率精准治疗组为4%,对照组为32%,差异有统计学意义(P=0.010)。静脉曲张治疗显效率精准治疗组为84%,对照组出血率为52%,差异有统计学意义(P=0.015)。并发症发生率在两组间差异无统计学意义(P>0.05)。聚桂醇和组织胶平均用量在两组间差异无统计学意义(P>0.05)。精准治疗组平均治疗时间为(32.60±6.44)min,对照组为(40.60±7.26)min,差异有统计学意义(P<0.0001);精准治疗组平均住院天数为(8.12±1.24)d,对照组为(9.12±1.39)d,差异有统计学意义(P=0.010)。结论 内镜下精准断流术治疗食管胃静脉曲张再出血率低、效果好、安全性高。
Objective To investigate the clinical efficacy of endoscopic selective varices devascularization and the modified Sandwich method on the treatment of esophagogastric varices. Methods 50 patients with esophagogastric varices were divided into therapy (endoscopic selective varices devascularization)group (n=25) and control group (n=25) by random number table method. The therapy group (n=25) received the treatment of endoscopic selective varices devascularization. The control group (n=25) was treated with modified Sandwich method injection. The success rate of hemostasis, rate of recurrent bleeding, rate of varices disappearance, complication rate, dosage of lauromacrogol and tissue adhesive, time of therapy and hospitalization days were compared and analyzed between the two groups. Results During the 3-month followup, the success rates of hemostasis were 100% in both groups 3 days after the treatments. The rates of recurrent bleeding in therapy group and control group were 4% and 32% respectively, with statistically significant difference (P=0.010). The rates of varices disappearance in therapy group and control group were 84%and 52% respectively, the difference (P=0.015) was statistically significant. There was no statistically significant difference in complication rates between the two groups(P>0.05). There was also no statistically significant difference in the average dosage of lauromacrogol and tissue adhesive between the two groups(P>0.05). The average time of therapy in therapy group and control group were(32.60±6.44)minutes and(40.60±7.26)minutes respectively, with statistically significant difference between the two groups(P=0.000). The average hospitalization days in therapy group and control group were(8.12±1.24)days and(9.12±1.39)days respectively, which is statistically significant difference between the two groups(P=0.010). Conclusion Endoscopic selective varices devascularization has the obvious advantage of a significant efficacy, low recurrence rate and high safety.
1、 肖亚南,张启芳,牛桂军,等. 内镜下精准断流术治疗食管胃静脉曲张的临床研究[J]. 微创医学,2018,13(1):9-11,16. 肖亚南,张启芳,牛桂军,等. 内镜下精准断流术治疗食管胃静脉曲张的临床研究[J]. 微创医学,2018,13(1):9-11,16.
2、 吴开玲.改良与传统三明治法治疗肝硬化胃静脉曲张出血的meta分析[D]. 重庆医科大学,2018:1-35. 吴开玲.改良与传统三明治法治疗肝硬化胃静脉曲张出血的meta分析[D]. 重庆医科大学,2018:1-35.
3、 吕美光,伍英,陈荣平,等. 内镜下组织胶联合硬化剂注射对胃底静脉破裂出血的临床观察[J]. 中国医药科学,2019,9(9):197-200. 吕美光,伍英,陈荣平,等. 内镜下组织胶联合硬化剂注射对胃底静脉破裂出血的临床观察[J]. 中国医药科学,2019,9(9):197-200.
4、 苏任腾.内镜下套扎术治疗食管静脉曲张破裂出血48例疗效观察[J]. 现代医院,2012,12(5):48-50. 苏任腾.内镜下套扎术治疗食管静脉曲张破裂出血48例疗效观察[J]. 现代医院,2012,12(5):48-50.
5、 刘和生,李桂友.组织胶内镜下注射联合套扎治疗食管胃底静脉曲张16例[J]. 广州医药,2012,43(3):25-27. 刘和生,李桂友.组织胶内镜下注射联合套扎治疗食管胃底静脉曲张16例[J]. 广州医药,2012,43(3):25-27.
6、 GARCIA-TSAO G,BOSCH J.Management of varices and variceal hemorrhage incirrhosis[J]. N Engl J Med,2010,362(9):823-832. GARCIA-TSAO G,BOSCH J.Management of varices and variceal hemorrhage incirrhosis[J]. N Engl J Med,2010,362(9):823-832.
7、 MOKDAD A A, LOPEZ A D, SHAHRAZ S, et al. Liver cirrhosis mortality in 187 countries between1980 and 2010: a systematic analysis[J]. BMC Med, 2014(12): 145. MOKDAD A A, LOPEZ A D, SHAHRAZ S, et al. Liver cirrhosis mortality in 187 countries between1980 and 2010: a systematic analysis[J]. BMC Med, 2014(12): 145.
8、 WANG F S, FAN J G, ZHANG Z, et al. The global burden of liver disease: the major impact of China[J]. Hepatol,2014, 60(6):2099-2108. WANG F S, FAN J G, ZHANG Z, et al. The global burden of liver disease: the major impact of China[J]. Hepatol,2014, 60(6):2099-2108.
9、 刘文娟,原丽莉,康艳,等. 内镜治疗食管胃底静脉曲张破裂出血281例临床分析[J]. 山西医药杂志,2018,47(15):1793-1795. 刘文娟,原丽莉,康艳,等. 内镜治疗食管胃底静脉曲张破裂出血281例临床分析[J]. 山西医药杂志,2018,47(15):1793-1795.
10、 曹传坤,孔德润.内镜下精准食管胃静脉曲张断流术83例初步研究[J]. 中华消化内镜杂志,2018,35(2):99-104. 曹传坤,孔德润.内镜下精准食管胃静脉曲张断流术83例初步研究[J]. 中华消化内镜杂志,2018,35(2):99-104.
11、 中华医学会消化内镜学分会食管胃静脉曲张学组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案(2009年)[J]. 中华消化内镜杂志,2010,27(1):1-4. 中华医学会消化内镜学分会食管胃静脉曲张学组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案(2009年)[J]. 中华消化内镜杂志,2010,27(1):1-4.
12、 李坪.食管胃底静脉曲张探索[M]. 北京:中国原子能出版社,2016:9-12. 李坪.食管胃底静脉曲张探索[M]. 北京:中国原子能出版社,2016:9-12.
13、 王艳玲,刘亭亭,张文辉.肝硬化门静脉高压症胃静脉曲张的诊治现状[J]. 中国医刊,2019,54(2):123-126. 王艳玲,刘亭亭,张文辉.肝硬化门静脉高压症胃静脉曲张的诊治现状[J]. 中国医刊,2019,54(2):123-126.
14、 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 中华内科杂志,2016,55(1):57-72. 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 中华内科杂志,2016,55(1):57-72.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录